Increasing use of radical prostatectomy for nonlethal prostate cancer in Sweden

Clinical Cancer Research

Volumn 18, Issue 24, 2012, Pages 6742-6747

  Etzioni, Ruth ^a   Mucci, Lorelei ^b,c   Chen, Shu ^a   Johansson, Jan Erik ^d   Fall, Katja ^d   Adami, Hans Olov ^b,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SPECIFIC SURVIVAL; COHORT ANALYSIS; FOLLOW UP; HEALTH CARE COST; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; RISK REDUCTION; SURVIVAL RATE; SWEDEN; TIME SERIES ANALYSIS; TREATMENT OUTCOME; TREND STUDY;

AGED; EARLY DETECTION OF CANCER; HEALTH SERVICES MISUSE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; SURVIVAL ANALYSIS; SWEDEN; TREATMENT OUTCOME;

EID: 84871224268     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-1537     Document Type: Article

References (30)

1. Reiner WG, Walsh PC. An anatomical approach to the surgical management of the dorsal vein and Santorini's plexus during radical retropubic surgery. J Urol 1979;121:198-200. (Pubitemid 9135005)
2. Walsh PC. Radical prostatectomy for the treatment of localized prostatic carcinoma. Urol Clin North Am 1980;7:583-91. (Pubitemid 11225745)
3. Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881-7. (Pubitemid 351767195)
4. Adami HO. The prostate cancer pseudo-epidemic. Acta Oncol 2010;49:298-304.
5. Welsh H. Should I be tested for cancer? Berkeley, CA: California University Press; 2004.
6. Cooperberg MR, Moul JW, Carroll PR. The changing face of prostate cancer. J Clin Oncol 2005;23:8146-51. (Pubitemid 46211547)
7. National Cancer Institute. Surveillance Epidemiology and End Results. SEER data 1973-2008; Available from: http://seer.cancer.gov.
8. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010;46:3040-52.
9. Jonsson H, Holmstrom B, Duffy SW, Stattin P. Uptake of prostate-specific antigen testing for early prostate cancer detection in Sweden. Int J Cancer 2010;129:1881-8.
10. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994;330:242-8. (Pubitemid 24034136)
11. Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, et al. Natural history of early, localized prostate cancer. JAMA 2004;291:2713-9. (Pubitemid 38725420)
12. Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009;302:1202-9.
13. Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101:374-83.
14. Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790-6. (Pubitemid 34988337)
15. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008;358:1250-61. (Pubitemid 351439226)
16. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984;23:305-13. (Pubitemid 15028463)
17. Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996;335:242-9. (Pubitemid 26249572)
18. Godtman R, Holmberg E, Stranne J, Hugosson J. High accuracy of Swedish death certificates in men participating in screening for prostate cancer: a comparative study of official death certificates with a cause of death committee using a standardized algorithm. Scand J Urol Nephrol 2011;45:226-32.
19. Fall K, Stromberg F, Rosell J, Andren O, Varenhorst E. Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008;42:352-7.
20. Corbiere F, Joly P. A SAS macro for parametric and semiparametric mixture cure models. Comput Methods Programs Biomed 2007;85:173-80. (Pubitemid 46108129)
21. Farewell VT. The use of mixture models for the analysis of survival data with long-term survivors. Biometrics 1982;38:1041-6.
22. Adolfsson J, Garmo H, Varenhorst E, Ahlgren G, Ahlstrand C, Andren O, et al. Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005. Scand J Urol Nephrol 2007;41:456-77. (Pubitemid 350207540)
23. Finne P, Fallah M, Hakama M, Ciatto S, Hugosson J, de Koning H, et al. Lead-time in the European randomised study of screening for prostate cancer. Eur J Cancer 2010;46:3102-8.
24. Weiss NS, Rossing MA. Healthy screened bias in epidemiologic studies of cancer incidence. Epidemiology 1996;7:319-22. (Pubitemid 126448330)
25. Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, et al. The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst 2007;99:1171-7. (Pubitemid 47233067)
26. Klein EA, Bianco FJ, Serio AM, Eastham JA, Kattan MW, Pontes JE, et al. Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories. J Urol 2008;179:2212-7.
27. Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004;96:1358-67. (Pubitemid 39406169)
28. Andersson SO, Andren O, Lyth J, Stark JR, Henriksson M, Adami HO, et al. Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4). Scand J Urol Nephrol 2011;45:177-83.
29. Sboner A, Demichelis F, Calza S, Pawitan Y, Setlur SR, Hoshida Y, et al. Molecular sampling of prostate cancer: a dilemma for predicting disease progression. BMC Med Genomics 2010;3:8.
30. Ip S, Dahabreh IJ, Chung M, Yu WW, Balk EM, Iovin RC, et al. An evidence review of active surveillance in men with localized prostate cancer. Rockville, MD: Agency for Healthcare Research and Quality; 2011.